Not Tagged
Not Tagged
['leukemia', 'myeloid', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
the differences in global inequities &amp; utilization of hsct for acute myeloid leukemia (aml) determines the potential for patient outcomes around the world, according to #ash22 
Breaking news, patient stories & FDA updates within the rare disease community. Listen to our podcast: https://t.co/xUkFDfCDUV, hosted by @GiulianaGrossi